NeuroSense Therapeutics Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire CAMBRIDGE, Mass., Aug. 30, 2024 CAMBRIDGE, Mass., Aug. 30, 2024 /PRNewswire/ --Β NeuroSense...
NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price PR Newswire CAMBRIDGE, Mass., Aug. 7, 2024 CAMBRIDGE, Mass., Aug. 7, 2024...
NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial PR Newswire CAMBRIDGE, Mass., Aug. 1, 2024 12-month data demonstrated regulation of iron levels, which...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 0.77519379845 | 1.29 | 1.455 | 1.19 | 160402 | 1.34426278 | CS |
4 | 0.4713 | 56.8722094847 | 0.8287 | 1.455 | 0.6729 | 409724 | 0.94984386 | CS |
12 | 0.24 | 22.641509434 | 1.06 | 1.5 | 0.512 | 424426 | 0.91588427 | CS |
26 | -0.23 | -15.0326797386 | 1.53 | 2.25 | 0.512 | 261966 | 1.05237494 | CS |
52 | 0.51 | 64.5569620253 | 0.79 | 2.33 | 0.4 | 420730 | 1.05756631 | CS |
156 | -3.25 | -71.4285714286 | 4.55 | 8.18 | 0.4 | 1043912 | 3.44920177 | CS |
260 | -3.25 | -71.4285714286 | 4.55 | 8.18 | 0.4 | 1043912 | 3.44920177 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.